Rafferty Asset Management
VBIV

Rafferty Asset Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Rafferty Asset Management’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,732
Closed -$42K – 1274
2022
Q2 		$42K Sell
1,732
-34,764
-95% -$1.18M ﹤0.01% 1110
2022
Q1 		$1.82M Buy
36,496
+8,276
+29% +$409K 0.01% 636
2021
Q4 		$1.98M Buy
28,220
+11,348
+67% +$956K 0.01% 665
2021
Q3 		$1.57M Sell
16,872
-337
-2% -$32K 0.01% 694
2021
Q2 		$1.73M Sell
17,209
-17,175
-50% -$1.67M 0.01% 728
2021
Q1 		$3.21M Buy
34,384
+24,934
+264% +$2.53M 0.02% 445
2020
Q4 		$780K Sell
9,450
-11,748
-55% -$1M 0.01% 577
2020
Q3 		$1.82M Buy
+21,198
New +$2.47M 0.02% 446

Other funds holding VBIV

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.51B AUM 37.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return